Abstract
Neurofibromatosis type 1 with dysmorphism and developmental delay is reported in a mother and two children. The son required treatment for a prostatic rhabdomyosarcoma. His sister has an optic pathway glioma. Fluorescence in situ hybridisation confirmed a submicroscopic deletion at 17q11.2. New evidence suggests an increased malignancy frequency in microdeletion cases.
Cite
CITATION STYLE
Lampe, A. K., Seymour, G., Thompson, P. W., Toutain, A., & Lynch, S. A. (2002). Familial neurofibromatosis microdeletion syndrome complicated by rhabdomyosarcoma. Archives of Disease in Childhood, 87(5), 444–445. https://doi.org/10.1136/adc.87.5.444
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.